Beaird Harris Wealth Management’s Gossamer Bio GOSS Stock Holding History

Beaird Harris Wealth Management’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1	Closed	-$62	–	612
2023 Q3	$62	Hold	1	–	–	﹤0.01%	444
2023 Q2	$89	Hold	1	–	–	﹤0.01%	445
2023 Q1	$94	Hold	1	–	–	﹤0.01%	466
2022 Q4	$161	Sell	1 -8	-89%	-$5.27K	﹤0.01%	720
2022 Q3	$9K	Hold	9	–	–	﹤0.01%	286
2022 Q2	$6K	Hold	9	–	–	﹤0.01%	289
2022 Q1	$6K	Hold	9	–	–	﹤0.01%	404
2021 Q4	$8K	Buy	+9	New	+$8.55K	﹤0.01%	430

Other funds holding GOSS

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Beaird Harris Wealth Management's GOSS Position: Q4 2023 in Review

Beaird Harris Wealth Management sold out of Gossamer Bio (GOSS) in Q4 2023, closing a stake of 1 share — an estimated $62 sold.

Beaird Harris Wealth Management first reported a position in GOSS in Q4 2021 and held it in 8 quarters. The position peaked at $9K in Q3 2022. 96 funds tracked by Wall St. Rank hold GOSS as of Q4 2023.

Beaird Harris Wealth Management reported no remaining Gossamer Bio position as of Q4 2023 after selling out during the quarter.
Beaird Harris Wealth Management sold 1 Gossamer Bio share in Q4 2023, an estimated $62.
Beaird Harris Wealth Management first reported a position in Gossamer Bio in Q4 2021 and held it in 8 quarters.
Beaird Harris Wealth Management's Gossamer Bio position peaked at $9K in Q3 2022.
96 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2023.

Based on Beaird Harris Wealth Management's 13F filing for Q4 2023, filed 27 Feb 2024.